TrialScientific reports2023

Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancer.

Giorgia Marisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.